ADVANCED BIODESIGN · ABD

Aminothiolester compound or derivative thereof for use as an immunomodulatory agent

N° IL304769A

Aminothiolester compounds or pharmaceutically acceptable salts thereof, for use for the treatment of cancer

N° US2023149378A1

AMINOTHIOLESTER COMPOUND OR DERIVATIVE THEREOF FOR USE AS AN IMMUNOMODULATORY AGENT

N° AU2022212597A1

AMINOTHIOLESTER COMPOUND OR DERIVATIVE THEREOF FOR USE AS AN IMMUNOMODULATORY AGENT

N° CA3206551A1

AMINOTHIOLESTER COMPOUND OR DERIVATIVE THEREOF FOR USE AS AN IMMUNOMODULATORY AGENT

N° WO2022162196A1

AMINOTHIOLESTER COMPOUND OR DERIVATIVE THEREOF FOR USE AS AN IMMUNOMODULATORY AGENT

N° EP4284360A1

면역조절제로 사용하기 위한 아미노티올에스테르 화합물또는 그의 유도체

N° KR20230136131A

Aminothiol ester compounds or derivatives thereof as immunomodulators

N° CN117320706A

Device for determining the attitude of a carrier, and associated system for assisting with the piloting of a carrier and determination method

N° US2024307406A1

AMINOTHIOLESTER COMPOUND OR DERIVATIVE THEREOF FOR USE AS AN IMMUNOMODULATORY AGENT.

N° MX2023008694A

AMINOTHIOLESTER COMPOUNDS AND USES THEREOF

N° ZA202201239B

Aminothiolester compounds and uses thereof

N° IL290031A

ΑΜΙΝΟΘΕΙΟΛΕΣΤΕΡΙΚΕΣ ΕΝΩΣΕΙΣ Ή ΦΑΡΜΑΚΕΥΤΙΚΩΣ ΑΠΟΔΕΚΤΑ ΑΛΑΤΑ ΑΥΤΩΝ, ΓΙΑ ΧΡΗΣΗ ΣΤΗΝ ΑΝΤΙΜΕΤΩΠΙΣΗ ΚΑΡΚΙΝΟΥ

N° CY1123950T1

ΣΥΝΔΥΑΣMΟΣ ΠΟΥ ΠΕΡΙΛΑΜΒΑΝΕΙ MΙA ΕΝΩΣΗ ΑΜΙΝΟΘΕΙΟΛΕΣΤΕΡΑ Ή ΕΝΑ ΦΑΡΜΑΚΕΥΤΙΚΩΣ ΑΠΟΔΕΚΤΟ ΑΛΑΣ ΑΥΤΗΣ ΚΑΙ MΙA ΕΝΩΣΗ ΙΚΑΝΗ ΑΥΞΗΣΗΣ ΤΟΥ ΕΠΙΠΕΔΟΥ Η2Ο2 ΣΤΑ ΚΑΡΚΙΝΙΚΑ ΚΥΤΤΑΡΑ ΕΝΟΣ ΥΠΟΚΕΙΜΕΝΟΥ

N° CY1123916T1

AMINOTHIOLESTER COMPOUND OR DERIVATIVE THEREOF FOR USE AS AN IMMUNOMODULATORY AGENT

N° EP4035666A1

Nanocapsule lipidique comprenant au moins un composé aminothiolester ou un de ses dérivés pharmaceutiquement acceptable

N° FR3119314A1

AMINOTHIOLESTER COMPOUNDS AND USES THEREOF

N° SI3833657T1

Aminothiolesters et leurs utilisations

N° MA57224B1

Amino thiol ester compound and use thereof

N° CN114341110A

AMINOTHIOLESTER COMPOUNDS AND USES THEREOF

N° US2022265845A1

AMINOTHIOLESTER COMPOUNDS AND USES THEREOF

N° HRP20220961T1

아미노티올에스터 화합물 및 이의 용도

N° KR20220039722A

Compuestos de aminotioléster y usos de los mismos

N° ES2929333T3

AMINOTHIOLESTER COMPOUNDS AND USES THEREOF

N° PL3833657T3

AMINOTHIOLESTER COMPOUNDS AND USES THEREOF.

N° MX2022001023A

AMINOTHIOLESTER COMPOUNDS AND USES THEREOF

N° WO2021019071A1

AMINOTHIOLESTER COMPOUNDS AND USES THEREOF

N° EP3833657A1

AMINOTHIOLESTER COMPOUNDS AND USES THEREOF

N° HUE059240T2

AMINOTHIOLESTER COMPOUNDS AND USES THEREOF

N° CA3145268A1

AMINOTHIOLESTER COMPOUNDS AND USES THEREOF

N° LT3833657T

Aminothiolester compounds and uses thereof

N° AU2020322170A1

Composto, processo para preparar um composto, composição farmacêutica e conjugado anticorpo-droga

N° BR112022001620A2

AMINOTHIOLESTER COMPOUNDS AND USES THEREOF

N° PT3833657T

Aminothiolester-forbindelser og anvendelser deraf

N° DK3833657T3

Specific substrate of an aldh isoenzyme

N° IL264481A

Monoclonal antibody specific for gamma-glutamyl-l-epsilon-lysine for the monitoring of apoptosis

N° IL263517A

MONOCLONAL ANTIBODY SPECIFIC FOR GAMMA-GLUTAMYL-L-EPSILON-LYSINE FOR THE MONITORING OF APOPTOSIS

N° ZA201807854B

COMBINATION COMPRISING AN AMINOTHIOLESTER COMPOUND OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A COMPOUND ABLE TO INCREASE THE H2O2 LEVEL IN CANCER CELLS OF A SUBJECT

N° HK1251477A1

AMINOTHIOLESTER COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, FOR USE IN THE TREATMENT OF CANCER

N° HK1251476A1

PROCESS FOR PREPARING AMINOTHIOL ESTER COMPOUNDS AND SALTS THEREOF

N° MX2018009831A

Process for preparing aminothiol ester compounds and salts thereof

N° IL261135A

PROCESS FOR PREPARING AMINOTHIOL ESTER COMPOUNDS AND SALTS THEREOF

N° ZA201805138B

COMBINATION COMPRISING AN AMINOTHIOLESTER COMPOUND OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A COMPOUND ABLE TO INCREASE THE H2O2 LEVEL IN CANCER CELLS OF A SUBJECT

N° ZA201802400B

AMINOTHIOLESTER COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, FOR USE IN THE TREATMENT OF CANCER

N° ZA201802399B

Combination comprising an aminothiolester compound or a pharmaceutically acceptable salt thereof and a compound able to increase the h2o2 level in cancer cells of a subject

N° IL258658A

Aminothiolester compounds or pharmaceutically acceptable salts thereof, for use in the treatment of cancer

N° IL258610A

COMBINATION COMPRISING AN AMINOTHIOLESTER COMPOUND OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A COMPOUND ABLE TO INCREASE THE H2O2 LEVEL IN CANCER CELLS OF A SUBJECT

N° MX2018004381A

AMINOTHIOLESTER COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, FOR USE IN THE TREATMENT OF CANCER

N° MX2018004380A

SPECIFIC SUBSTRATE OF AN ALDH ISOENZYME

N° CN109715822A

SPECIFIC SUBSTRATE OF AN ALDH ISOENZYME

N° EP3491143A1

Specific substrate of an ALDH isoenzyme

N° US2019233871A1

SPECIFIC SUBSTRATE OF AN ALDH ISOENZYME

N° WO2018019927A1

SPECIFIC SUBSTRATE OF AN ALDH ISOENZYME

N° CA3031587A1

MONOCLONAL ANTIBODY SPECIFIC FOR GAMMA-GLUTAMYL-L-EPSILON-LYSINE FOR THE MONITORING OF APOPTOSIS

N° EP3469371A1

Monoclonal antibody specific for gamma-glutamyl-l-epsilon-lysine for the monitoring of apoptosis

N° US2019169313A1

anticorpo monoclonal isolado, método para medir o nível de gama-glutamil-l-epsilon-lisina (ggel), método ex vivo para o monitoramento de apoptose, uso de um anticorpo monoclonal específico para gama-glutamil-l-epsilon-lisina (ggel), métodos para monitorar a eficácia de um tratamento indutor de apoptose, método de tratamento de uma doença associada a apoptose desregulada, kit para o monitoramento de apoptose, método de tratamento de sepse e dispositivo de imunoensaio de fluxo lateral

N° BR112018076005A2

MONOCLONAL ANTIBODY SPECIFIC FOR GAMMA-GLUTAMYL-L-EPSILON-LYSINE FOR THE MONITORING OF APOPTOSIS

N° WO2017216227A1

MONOCLONAL ANTIBODY SPECIFIC FOR GAMMA-GLUTAMYL-L-EPSILON-LYSINE FOR THE MONITORING OF APOPTOSIS

N° CA3027452A1

PROCESS FOR PREPARING AMINOTHIOL ESTER COMPOUNDS AND SALTS THEREOF

N° CA3015021A1

PROCESS FOR PREPARING AMINOTHIOL ESTER COMPOUNDS AND SALTS THEREOF

N° HUE047748T2

Process for preparing aminothiol ester compounds and salts thereof

N° US2019047948A1

Fremgangsmåde til fremstilling af aminothiolesterforbindelser og salte deraf

N° DK3416944T3

PROCESS FOR PREPARING AMINOTHIOL ESTER COMPOUNDS AND SALTS THEREOF

N° SI3416944T1

PROCESS FOR PREPARING AMINOTHIOL ESTER COMPOUNDS AND SALTS THEREOF

N° PL3416944T3

Procedimiento para la preparación de compuestos aminotiolesteres y sus sales

N° ES2764720T3

PROCESS FOR PREPARING AMINOTHIOL ESTER COMPOUNDS AND SALTS THEREOF

N° WO2017140754A1

Método para preparar compostos do éster de aminotiol e seus sais

N° BR112018016656A2

PROCESS FOR PREPARING AMINOTHIOL ESTER COMPOUNDS AND SALTS THEREOF

N° LT3416944T

PROCESS FOR PREPARING AMINOTHIOL ESTER COMPOUNDS AND SALTS THEREOF

N° EP3416944A1

COMBINATION COMPRISING AN AMINOTHIOLESTER COMPOUND OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A COMPOUND ABLE TO INCREASE THE H2O2 LEVEL IN CANCER CELLS OF A SUBJECT

N° SMT202100270T1

AMINOTHIOLESTER COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, FOR USE IN THE TREATMENT OF CANCER

N° WO2017064247A1

COMPUESTOS DE AMINOTIOLÉSTER O LAS SALES FARMACÉUTICAMENTE ACEPTABLES DEL MISMO, PARA USAR EN EL TRATAMIENTO DEL CÁNCER

N° AR106352A1

AMINOTHIOLESTER COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, FOR USE IN THE TREATMENT OF CANCER

N° RS61630B1

AMINOTHIOLESTER COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, FOR USE IN THE TREATMENT OF CANCER

N° HUE053725T2

Compuestos de aminotioléster o sales farmacéuticamente aceptables de los mismos, para utilizar en el tratamiento del cáncer

N° ES2867965T3

COMBINATION COMPRISING AN AMINOTHIOLESTER COMPOUND OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A COMPOUND ABLE TO INCREASE THE H2O2 LEVEL IN CANCER CELLS OF A SUBJECT

N° CA3001201A1

COMBINATION COMPRISING AN AMINOTHIOLESTER COMPOUND OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A COMPOUND ABLE TO INCREASE THE H2O2 LEVEL IN CANCER CELLS OF A SUBJECT

N° PT3362094T

COMBINATION COMPRISING AN AMINOTHIOLESTER COMPOUND OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A COMPOUND ABLE TO INCREASE THE H2O2 LEVEL IN CANCER CELLS OF A SUBJECT

N° RS61572B1

COMBINATION COMPRISING AN AMINOTHIOLESTER COMPOUND OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A COMPOUND ABLE TO INCREASE THE H2O2 LEVEL IN CANCER CELLS OF A SUBJECT

N° HUE054247T2

AMINOTHIOLESTER COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, FOR USE IN THE TREATMENT OF CANCER

N° US2018296548A1

Aminothiolesterforbindelser eller farmaceutisk acceptable salte deraf, til anvendelse ved behandling af cancer

N° DK3362056T3

COMBINATION COMPRISING AN AMINOTHIOLESTER COMPOUND OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A COMPOUND ABLE TO INCREASE THE H2O2 LEVEL IN CANCER CELLS OF A SUBJECT

N° SI3362094T1

COMBINATION COMPRISING AN AMINOTHIOLESTER COMPOUND OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A COMPOUND ABLE TO INCREASE THE H2O2 LEVEL IN CANCER CELLS OF A SUBJECT

N° LT3362094T

COMBINATION COMPRISING AN AMINOTHIOLESTER COMPOUND OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A COMPOUND ABLE TO INCREASE THE H2O2 LEVEL IN CANCER CELLS OF A SUBJECT

N° PL3362094T3

Combination comprising an aminothiolester compound or a pharmaceutically acceptable salt thereof and a compound able to increase the H2o2 level in cancer cells of a subject

N° CN108348612A

AMINOTHIOLESTER COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, FOR USE IN THE TREATMENT OF CANCER

N° CA3001204A1

AMINOTHIOLESTER COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, FOR USE IN THE TREATMENT OF CANCER

N° EP3362056A1

AMINOTHIOLESTER COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, FOR USE IN THE TREATMENT OF CANCER

N° HRP20210359T1

AMINOTHIOLESTER COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, FOR USE IN THE TREATMENT OF CANCER

N° CN108348485A

COMBINATION COMPRISING AN AMINOTHIOLESTER COMPOUND OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A COMPOUND ABLE TO INCREASE THE H2O2 LEVEL IN CANCER CELLS OF A SUBJECT

N° WO2017064241A1

COMBINACIÓN QUE COMPRENDE UN COMPUESTO AMINOTIOLÉSTER O UNA SAL FARMACÉUTICAMENTE ACEPTABLE DEL MISMO Y UN COMPUESTO CON CAPACIDAD PARA AUMENTAR EL NIVEL DEL NIVEL EL H₂O₂ EN LAS CÉLULAS CANCEROSAS DE UN SUJETO, PARA USAR COMO MEDICAMENTO

N° AR106351A1

combinação, produto, composição farmacêutica e método para a seleção de um indivíduo

N° BR112018007480A2

Combinación que comprende un compuesto de aminotioléster o una sal farmacéuticamente aceptable del mismo y un compuesto capaz de aumentar el nivel de H2O2 en células cancerosas de un sujeto

N° ES2870508T3

uso do composto de fórmula i e método

N° BR112018007310A2

AMINOTHIOLESTER COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, FOR USE IN THE TREATMENT OF CANCER

N° SMT202100271T1

COMBINATION COMPRISING AN AMINOTHIOLESTER COMPOUND OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A COMPOUND ABLE TO INCREASE THE H2O2 LEVEL IN CANCER CELLS OF A SUBJECT

N° EP3362094A1

AMINOTHIOLESTER COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, FOR USE IN THE TREATMENT OF CANCER

N° PL3362056T3

AMINOTHIOLESTER COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, FOR USE IN THE TREATMENT OF CANCER

N° SI3362056T1

Kombination omfattende en aminothiolesterforbindelse eller et farmaceutisk acceptabelt salt deraf og en forbindelse, der er i stand til at øge H2O2-niveauet i cancerceller i et individ

N° DK3362094T3

COMBINATION COMPRISING AN AMINOTHIOLESTER COMPOUND OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A COMPOUND ABLE TO INCREASE THE H2O2 LEVEL IN CANCER CELLS OF A SUBJECT

N° HRP20210358T1